🇺🇸 FDA
Pipeline program

AXS-07 (meloxicam-rizatriptan)

AXS-07-304

Phase 3 small_molecule completed

Quick answer

AXS-07 (meloxicam-rizatriptan) for Migraine is a Phase 3 program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Axsome Therapeutics
Indication
Migraine
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials